These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

371 related items for PubMed ID: 10865059

  • 1. On the altered expression of tyrosine hydroxylase and calbindin-D 28kD immunoreactivities and viability of neurons in the ventral tegmental area of Tsai following injections of 6-hydroxydopamine in the medial forebrain bundle in the rat.
    Tan Y, Williams EA, Lancia AJ, Zahm DS.
    Brain Res; 2000 Jun 30; 869(1-2):56-68. PubMed ID: 10865059
    [Abstract] [Full Text] [Related]

  • 2. Calbindin-D 28kD immunofluorescence in ventral mesencephalic neurons labeled following injections of Fluoro-Gold in nucleus accumbens subterritories: inverse relationship relative to known neurotoxin vulnerabilities.
    Tan Y, Williams ES, Zahm DS.
    Brain Res; 1999 Oct 09; 844(1-2):67-77. PubMed ID: 10536262
    [Abstract] [Full Text] [Related]

  • 3. Enhanced glutamatergic phenotype of mesencephalic dopamine neurons after neonatal 6-hydroxydopamine lesion.
    Dal Bo G, Bérubé-Carrière N, Mendez JA, Leo D, Riad M, Descarries L, Lévesque D, Trudeau LE.
    Neuroscience; 2008 Sep 22; 156(1):59-70. PubMed ID: 18706980
    [Abstract] [Full Text] [Related]

  • 4. Susceptibility of ascending dopamine projections to 6-hydroxydopamine in rats: effect of hypothermia.
    Grant RJ, Clarke PB.
    Neuroscience; 2002 Sep 22; 115(4):1281-94. PubMed ID: 12453497
    [Abstract] [Full Text] [Related]

  • 5. Altered melatonin MT1 receptor expression in the ventral midbrain following 6-hydroxydopamine lesions in the rat medial forebrain bundle.
    Kang NH, Carriere CH, Bahna SG, Niles LP.
    Brain Res; 2016 Dec 01; 1652():89-96. PubMed ID: 27693415
    [Abstract] [Full Text] [Related]

  • 6. Failure of estrogen to protect the substantia nigra pars compacta of female rats from lesion induced by 6-hydroxydopamine.
    Ferraz AC, Xavier LL, Hernandes S, Sulzbach M, Viola GG, Anselmo-Franci JA, Achaval M, Da Cunha C.
    Brain Res; 2003 Oct 03; 986(1-2):200-5. PubMed ID: 12965246
    [Abstract] [Full Text] [Related]

  • 7. Loss of cannabinoid CB1 receptor expression in the 6-hydroxydopamine-induced nigrostriatal terminal lesion model of Parkinson's disease in the rat.
    Walsh S, Mnich K, Mackie K, Gorman AM, Finn DP, Dowd E.
    Brain Res Bull; 2010 Apr 05; 81(6):543-8. PubMed ID: 20097273
    [Abstract] [Full Text] [Related]

  • 8. GFRalpha-1 mRNA in dopaminergic and nondopaminergic neurons in the substantia nigra and ventral tegmental area.
    Sarabi A, Hoffer BJ, Olson L, Morales M.
    J Comp Neurol; 2001 Dec 10; 441(2):106-17. PubMed ID: 11745638
    [Abstract] [Full Text] [Related]

  • 9. Decreased susceptibility to oxidative stress underlies the resistance of specific dopaminergic cell populations to paraquat-induced degeneration.
    McCormack AL, Atienza JG, Langston JW, Di Monte DA.
    Neuroscience; 2006 Aug 25; 141(2):929-937. PubMed ID: 16677770
    [Abstract] [Full Text] [Related]

  • 10. Adrenalectomy counteracts the local modulation of astroglial fibroblast growth factor system without interfering with the pattern of 6-OHDA-induced dopamine degeneration in regions of the ventral midbrain.
    Chadi G, Silva C, Maximino JR, Fuxe K, da Silva GO.
    Brain Res; 2008 Jan 23; 1190():23-38. PubMed ID: 18086466
    [Abstract] [Full Text] [Related]

  • 11. Calretinin and calbindin-D28k in dopaminergic neurons of the rat midbrain: a triple-labeling immunohistochemical study.
    Nemoto C, Hida T, Arai R.
    Brain Res; 1999 Oct 30; 846(1):129-36. PubMed ID: 10536220
    [Abstract] [Full Text] [Related]

  • 12. Dopaminergic neurons expressing calbindin in normal and parkinsonian monkeys.
    Lavoie B, Parent A.
    Neuroreport; 1991 Oct 30; 2(10):601-4. PubMed ID: 1684519
    [Abstract] [Full Text] [Related]

  • 13. Calretinin-containing axons and neurons are resistant to an intrastriatal 6-hydroxydopamine lesion.
    Tsuboi K, Kimber TA, Shults CW.
    Brain Res; 2000 Jun 02; 866(1-2):55-64. PubMed ID: 10825480
    [Abstract] [Full Text] [Related]

  • 14. Midbrain dopaminergic neurons in the mouse: co-localization with Calbindin-D28K and calretinin.
    Liang CL, Sinton CM, German DC.
    Neuroscience; 1996 Nov 02; 75(2):523-33. PubMed ID: 8931015
    [Abstract] [Full Text] [Related]

  • 15. Vulnerabilities of ventral mesencephalic neurons projecting to the nucleus accumbens following infusions of 6-hydroxydopamine into the medial forebrain bundle in the rat.
    Lancia AJ, Williams EA, McKnight LV, Zahm DS.
    Brain Res; 2004 Jan 30; 997(1):119-27. PubMed ID: 14715157
    [Abstract] [Full Text] [Related]

  • 16. Structure of longitudinal brain zones that provide the origin for the substantia nigra and ventral tegmental area in human embryos, as revealed by cytoarchitecture and tyrosine hydroxylase, calretinin, calbindin, and GABA immunoreactions.
    Verney C, Zecevic N, Puelles L.
    J Comp Neurol; 2001 Jan 01; 429(1):22-44. PubMed ID: 11086287
    [Abstract] [Full Text] [Related]

  • 17. NF-kappaB contributes to 6-hydroxydopamine-induced apoptosis of nigral dopaminergic neurons through p53.
    Liang ZQ, Li YL, Zhao XL, Han R, Wang XX, Wang Y, Chase TN, Bennett MC, Qin ZH.
    Brain Res; 2007 May 11; 1145():190-203. PubMed ID: 17368433
    [Abstract] [Full Text] [Related]

  • 18. Involvement of astroglial fibroblast growth factor-2 and microglia in the nigral 6-OHDA parkinsonism and a possible role of glucocorticoid hormone on the glial mediated local trophism and wound repair.
    Silva C, Fuxe K, Chadi G.
    J Neural Transm Suppl; 2009 May 11; (73):185-202. PubMed ID: 20411778
    [Abstract] [Full Text] [Related]

  • 19. Chronic intranigral administration of brain-derived neurotrophic factor produces striatal dopaminergic hypofunction in unlesioned adult rats and fails to attenuate the decline of striatal dopaminergic function following medial forebrain bundle transection.
    Lapchak PA, Beck KD, Araujo DM, Irwin I, Langston JW, Hefti F.
    Neuroscience; 1993 Apr 11; 53(3):639-50. PubMed ID: 8098137
    [Abstract] [Full Text] [Related]

  • 20. Characterization of liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in rat partial and full nigral 6-hydroxydopamine lesion models of Parkinson's disease.
    Hansen HH, Fabricius K, Barkholt P, Mikkelsen JD, Jelsing J, Pyke C, Knudsen LB, Vrang N.
    Brain Res; 2016 Sep 01; 1646():354-365. PubMed ID: 27233809
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.